Evidence map›Paper›PMID 42376331›Full record

ArticleAsian journal of pharmaceutical sciences2026

An opposite pH-responsiveness "gating" strategy: Intelligent sporopollenin exine armor for targeted therapy of colitis.

Jun Liu, Zifang Ding, Jianxiong Wei, Yuanqing Li, Xiaoqing Wang, Xiaodan Yan, Dan Li, Tiantian Ye, Shujun Wang, Jin Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of pharmaceutical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun LiuWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016 China.
Zifang DingWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016 China.
Jianxiong WeiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016 China.
Yuanqing LiCollege of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016 China.
Xiaoqing WangCollege of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016 China.
Xiaodan YanSchool of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016 China.
Dan LiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016 China.
Tiantian YeSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016 China.
Shujun WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016 China.
Jin SunWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional therapy for ulcerative colitis (UC) is often limited by insufficient colonic targeting, short local retention and poor cellular drug uptake at lesion sites. Here, we develop a biomimetic colon-targeted delivery system based on an opposite pH-responsive "gating" strategy.

Indexed as

5-aminosalicylic acidButyric acidChrysanthemum sporopolleninColon-targetedDrug delivery systemUlcerative colitis

Identifiers

PMID42376331
PMCPMC13312463

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.